FR2327764A1 - Nouvelles compositions pharmaceutiques et leur preparation - Google Patents

Nouvelles compositions pharmaceutiques et leur preparation

Info

Publication number
FR2327764A1
FR2327764A1 FR7630866A FR7630866A FR2327764A1 FR 2327764 A1 FR2327764 A1 FR 2327764A1 FR 7630866 A FR7630866 A FR 7630866A FR 7630866 A FR7630866 A FR 7630866A FR 2327764 A1 FR2327764 A1 FR 2327764A1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical compositions
new pharmaceutical
new
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7630866A
Other languages
English (en)
French (fr)
Other versions
FR2327764B1 (es
Inventor
Lothar Ehrhardt
Volker Hartmann
Ludwig Patt
Karl-Heinz Otto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2327764A1 publication Critical patent/FR2327764A1/fr
Application granted granted Critical
Publication of FR2327764B1 publication Critical patent/FR2327764B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7630866A 1975-10-17 1976-10-14 Nouvelles compositions pharmaceutiques et leur preparation Granted FR2327764A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2546577A DE2546577B2 (de) 1975-10-17 1975-10-17 Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden

Publications (2)

Publication Number Publication Date
FR2327764A1 true FR2327764A1 (fr) 1977-05-13
FR2327764B1 FR2327764B1 (es) 1979-03-02

Family

ID=5959411

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7630866A Granted FR2327764A1 (fr) 1975-10-17 1976-10-14 Nouvelles compositions pharmaceutiques et leur preparation

Country Status (28)

Country Link
JP (1) JPS5854122B2 (es)
AT (1) AT362510B (es)
AU (1) AU508628B2 (es)
BE (1) BE847368A (es)
CA (1) CA1079641A (es)
CH (1) CH643737A5 (es)
CS (1) CS199647B2 (es)
DE (1) DE2546577B2 (es)
DK (1) DK146194C (es)
ES (1) ES452420A1 (es)
FI (1) FI762875A (es)
FR (1) FR2327764A1 (es)
GB (1) GB1560406A (es)
GR (1) GR61268B (es)
HK (1) HK3183A (es)
HU (1) HU172533B (es)
IE (1) IE43778B1 (es)
IL (1) IL50686A (es)
MY (1) MY8400063A (es)
NL (1) NL184558C (es)
NO (1) NO144468C (es)
NZ (1) NZ182341A (es)
PH (1) PH14513A (es)
PT (1) PT65719B (es)
SE (1) SE430379B (es)
SG (1) SG63082G (es)
SU (1) SU1165223A3 (es)
ZA (1) ZA766166B (es)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454804A1 (fr) * 1979-04-26 1980-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2508313A1 (fr) * 1981-06-24 1982-12-31 Sandoz Sa Nouvelles formulations pharmaceutiques a base d'alcaloides de l'ergot de seigle et leur preparation
EP0277092A1 (de) * 1987-01-14 1988-08-03 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
FR2610827A1 (fr) * 1987-02-18 1988-08-19 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
EP0664131A1 (de) * 1994-01-21 1995-07-26 Krewel Meuselbach GmbH Optimal freisetzende Kava-Extrakte
WO2001039742A2 (en) * 1999-12-03 2001-06-07 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
US4411882A (en) 1978-12-21 1983-10-25 Sandoz Ltd. Galenical compositions
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
CO4970793A1 (es) * 1997-12-22 2000-11-07 Schering Corp Composicion para dispersion molecular con biodisponibilidad aumentada
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PT1638527E (pt) * 2003-06-27 2007-02-28 Bioprogress Spa Produto compósito obtido por co-trituração de um princípio activo com um copolímero de n-vinil-2-pirrolidona/acetato de vinilo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175430A (en) * 1966-04-07 1969-12-23 Sandoz Ltd Pharmaceutical Compositions containing Ergot Alkaloids

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2454804A1 (fr) * 1979-04-26 1980-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2508313A1 (fr) * 1981-06-24 1982-12-31 Sandoz Sa Nouvelles formulations pharmaceutiques a base d'alcaloides de l'ergot de seigle et leur preparation
EP0277092A1 (de) * 1987-01-14 1988-08-03 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
FR2610827A1 (fr) * 1987-02-18 1988-08-19 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
EP0280613A1 (fr) * 1987-02-18 1988-08-31 Pierre Fabre Medicament Comprimé de dihydroergotamine (D.H.E.) du type à matrice hydrophile et son procédé de fabrication
EP0664131A1 (de) * 1994-01-21 1995-07-26 Krewel Meuselbach GmbH Optimal freisetzende Kava-Extrakte
WO2001039742A2 (en) * 1999-12-03 2001-06-07 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
WO2001039742A3 (en) * 1999-12-03 2001-12-13 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
EP1512403A1 (en) * 1999-12-03 2005-03-09 Polichem S.A. Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
US7771746B2 (en) 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof

Also Published As

Publication number Publication date
FI762875A (es) 1977-04-18
PT65719A (fr) 1976-11-01
IE43778L (en) 1977-04-17
DK454176A (da) 1977-04-18
IL50686A (en) 1979-05-31
AT362510B (de) 1981-05-25
IL50686A0 (en) 1976-12-31
DE2546577B2 (de) 1981-04-02
AU1875476A (en) 1978-04-20
NZ182341A (en) 1978-09-20
DK146194B (da) 1983-07-25
IE43778B1 (en) 1981-05-20
ATA767976A (de) 1980-10-15
NL184558C (nl) 1989-09-01
CS199647B2 (en) 1980-07-31
NL184558B (nl) 1989-04-03
ZA766166B (en) 1978-05-30
AU508628B2 (en) 1980-03-27
GB1560406A (en) 1980-02-06
ES452420A1 (es) 1978-04-16
JPS5251014A (en) 1977-04-23
CA1079641A (en) 1980-06-17
MY8400063A (en) 1984-12-31
NL7611295A (nl) 1977-04-19
JPS5854122B2 (ja) 1983-12-02
DE2546577A1 (de) 1977-04-21
DK146194C (da) 1984-01-02
NO144468C (no) 1981-09-09
SE7611189L (sv) 1977-04-18
SU1165223A3 (ru) 1985-06-30
SE430379B (sv) 1983-11-14
CH643737A5 (en) 1984-06-29
BE847368A (fr) 1977-04-15
GR61268B (en) 1978-10-17
NO144468B (no) 1981-06-01
PH14513A (en) 1981-08-24
FR2327764B1 (es) 1979-03-02
PT65719B (fr) 1978-06-12
NO763446L (es) 1977-04-19
SG63082G (en) 1983-09-09
HU172533B (hu) 1978-09-28
HK3183A (en) 1983-01-20

Similar Documents

Publication Publication Date Title
FR2276832A1 (fr) Nouvelles compositions pharmaceutiques et leur preparation
BE839615A (fr) Nouvelles amidinourees, leur preparation et leur emploi
FR2327764A1 (fr) Nouvelles compositions pharmaceutiques et leur preparation
FR2347365A1 (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE843152A (fr) Nouvelles cephalosporimes, leur preparation et leur emploi
BE832921A (fr) Nouvelles rifamycines et leur preparation
BE833369A (fr) Nouvelles benzodiazepines et leur preparation
BE841797A (fr) Compositions photosensibles et leur application
FR2320745A1 (fr) Nouveaux agents anti-flammatoires imidazoles, leur preparation et compositions pharmaceutiques
BE847165A (fr) Nouvelles compositions detergentes et leur preparation,
BE871857A (fr) Nouvelles piperazines disubstituees, leur procedes de preparation et les compositions pharmaceutiques les renfermant
BE825982A (fr) Triazoloquinazolines et leur preparation
BE831041A (fr) Nouvelles compositions galeniques et leur preparation
BE844029A (fr) Diepoxy-androstanes et leur preparation
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
BE842348A (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant
BE869560R (fr) Nouvelles solutions pharmaceutiques stables et leur preparation
BE830442A (fr) Nouvelles benzylamines leur preparation et les compositions pharmaceutiques en contenant
BE846502A (fr) Agents antimicrobiens et leur preparation
BE826925A (fr) Nouvelles pyrrolodiazepines et leur preparation
BE840608A (fr) Nouvelles compositions pharmaceutiques
BE820256A (fr) Nouvelles phenoxyalkylamines et leur preparation
FR2287220A1 (fr) Nouvelles compositions pharmaceutiques anti-inflammatoires et leur procede de preparation
FR2313358A1 (fr) Urethanne-polythiols et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse